Prostate Cancer - Results from #520

Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborative. September 30, 2022

Flare on [18F]PSMA-1007 PET/CT after short-term androgen deprivation therapy and its correlation to FDG uptake: possible marker of tumor aggressiveness in treatment-naïve metastatic prostate cancer patients. September 30, 2022

A decade of declining prostatectomy margin positivity within a prostate cancer clinical quality registry. September 30, 2022

A SelectMDx/magnetic resonance imaging-based nomogram to diagnose prostate cancer. September 30, 2022

Could YouTubeTM encourage men on prostate checks? A contemporary analysis. September 30, 2022

Protein and amino acid intakes in relation to prostate cancer risk and mortality-A prospective study in the European Prospective Investigation into Cancer and Nutrition. September 29, 2022

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer. September 29, 2022

Freely Available, Fully Automated AI-Based Analysis of Primary Tumour and Metastases of Prostate Cancer in Whole-Body [18F]-PSMA-1007 PET-CT. September 29, 2022

Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy. September 29, 2022

Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer. September 29, 2022

A Matched-Pair Analysis after Robotic and Retropubic Radical Prostatectomy: A New Definition of Continence and the Impact of Different Surgical Techniques. September 29, 2022

Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer September 28, 2022

Standard and hypofractionated dose escalation to intraprostatic tumour nodules in localised prostate cancer: 5 year efficacy and toxicity in the DELINEATE trial. September 28, 2022

An overview of prostate cancer (PCa) diagnosis: Potential role of miRNAs. September 28, 2022

Predicting Local Failure after Partial Prostate Re-Irradiation Using a Dosiomic-Based Machine Learning Model. September 28, 2022

Value of magnetic resonance imaging/ultrasound fusion prostate biopsy to select patients for focal therapy. September 28, 2022

PSA-Stratified Performance of [18F]DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer Patients under Androgen Deprivation Therapy. September 28, 2022

Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database. September 27, 2022

Automatic segmentation of prostate and extracapsular structures in MRI to predict needle deflection in percutaneous prostate intervention. September 27, 2022

Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage. September 27, 2022

Page 27 of 1276

email news signup